Clinical Trials

Clinical trials are essential to evaluating the safety and efficacy of new therapies for patients living with immunologic conditions. Availability of data from clinical trials sponsored by UCB provides transparency and fosters advances in patient care. As part of our commitment to patients and the healthcare community at large, UCB shares information about our clinical trials and makes the results of these studies publicly available. The interventions being studied and their uses may be investigational and not approved by the US Food and Drug Administration. Note: Searching by the generic name (e.g., certolizumab pegol) may deliver different results than a search by the code name (e.g., CDP870); therefore, it may be necessary to search by both for complete results.